How Sarcoidosis Affects the Heart and Lungs
Sarcoidosis causes life-threatening complications in both organs through granulomatous inflammation: in the lungs, it leads to progressive pulmonary fibrosis and respiratory failure in advanced cases, while cardiac involvement causes sudden cardiac death from arrhythmias, heart block, and congestive heart failure from myocarditis 1.
Pulmonary Involvement
The lungs are affected in over 90% of sarcoidosis cases 2. The disease creates nonnecrotizing granulomas throughout the pulmonary tissue, which can progress along a spectrum:
- Asymptomatic disease: Many patients have no symptoms initially, discovered incidentally on chest imaging showing bilateral hilar adenopathy
- Progressive disease: Granulomas evolve into pulmonary fibrosis, causing irreversible lung damage
- End-stage complications: Progressive fibrosis leads to emphysema, cor pulmonale, and ultimately respiratory failure 3
Pulmonary sarcoidosis is the leading cause of death in this disease 4, 5. The fibrotic phenotype carries particularly high morbidity and mortality, often complicated by chronic pulmonary aspergillosis and sarcoidosis-associated pulmonary hypertension 5.
Key Clinical Pitfall
The lungs may appear minimally involved on initial presentation, but disease can progress insidiously. Mortality among African American women with sarcoidosis is 2.4 times higher than matched controls without the disease 1, emphasizing the need for vigilant monitoring even in seemingly mild cases.
Cardiac Involvement
Cardiac sarcoidosis occurs in approximately 30% of systemic sarcoidosis patients 6, though it is frequently underdiagnosed because it can be clinically silent until catastrophic events occur 6, 7.
The heart can be affected in any location, producing three major life-threatening manifestations:
- Conduction abnormalities: AV block and bundle branch blocks requiring pacemaker implantation 6, 3
- Arrhythmias: Ventricular tachycardia and fibrillation leading to sudden cardiac death—often the first presentation 7, 8
- Cardiomyopathy: Granulomatous myocarditis causing heart failure, which can be acute or progress chronically 1, 3
Critical Diagnostic Challenge
Cardiac sarcoidosis is notoriously difficult to diagnose 6. Endomyocardial biopsy has high specificity but poor sensitivity due to patchy, focal involvement 8. Advanced imaging with cardiac MRI and FDG-PET (with prolonged fasting protocols) are now essential diagnostic tools 2, 8.
Race-Based Considerations
Cardiac involvement is significantly influenced by race 4, with certain populations at higher risk for cardiac manifestations and worse outcomes.
Mortality Impact
Both cardiac and pulmonary involvement directly cause death in sarcoidosis 1:
- Pulmonary: Death from progressive fibrosis and respiratory failure
- Cardiac: Sudden cardiac death from arrhythmias or progressive heart failure from myocarditis
The unpredictable nature of cardiac sarcoidosis makes it particularly dangerous—patients can experience sudden cardiac death as their initial manifestation without prior symptoms 4, 7.
Clinical Algorithm for Monitoring
Given the mortality risk, all sarcoidosis patients require:
- Baseline cardiac evaluation: ECG, echocardiogram, and consider cardiac MRI or PET/CT even without symptoms 2, 8
- Pulmonary function monitoring: Serial spirometry and imaging to detect progressive fibrosis 5
- High suspicion threshold: Any conduction abnormality, arrhythmia, or unexplained dyspnea warrants aggressive cardiac workup 6
- Pacemaker/ICD consideration: For any significant conduction disease or ventricular arrhythmias 3
The multisystem nature means that isolated pulmonary disease can have concurrent silent cardiac involvement, and vice versa 9.